சோதனை இருதய மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சோதனை இருதய மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சோதனை இருதய மருந்து Today - Breaking & Trending Today

DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke


Press release content from Business Wire. The AP news staff was not involved in its creation.
DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke
March 9, 2021 GMT
MINNEAPOLIS (BUSINESS WIRE) Mar 9, 2021
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will host a key opinion leader (KOL) webinar on DM199, the Company’s lead asset for the treatment of Acute Ischemic Stroke (AIS), on Friday, March 19, 2021 at 12:00pm Eastern Time.
The webinar will feature presentations by KOLs Scott Kasner, M.D., University of Pennsylvania, and Paolo Madeddu, M.D., University of Bristol, who will discuss the current treatment landscape and unmet medical need in treating patients with AIS and the rationale for the treatment of stroke and stroke recurrence with DM199. Drs. Kasner and Madeddu will be ....

United States , Kols Scott Kasner , Scotte Kasner , Scott Kellen , Paolo Madeddu , Tim Mccarthy , American Heart Association , Stroke Council Award , Stroke Center , Division Of Stroke , University Of Bristol Medical School , University Of Bristol , Stroke Oversight Committee , Clinical Affairs , Yale University , Lifesci Advisors , University Of Sassari , School Of Clinical Sciences , Diamedica Therapeutics Inc , University Of Texas At Houston , University Of Pennsylvania , American Academy Of Neurology , Duke University , Stroke Council Leadership Committee , Medica Therapeutics , Acute Ischemic Stroke ,

David Julius and Ardem Patapoutian win the Frontiers of Knowledge Award in Biomedicine


 E-Mail
Credit: BBVA Foundation
The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this thirteenth edition to David Julius, from the University of California, San Francisco, and Ardem Patapoutian, from the Scripps Institute, La Jolla (United States), for identifying the receptors that enable us to sense temperature, pain and pressure.
Temperature, pain and pressure are part of our sense of touch, perhaps the least understood of the five main senses of humans, read the opening words of the citation. Julius and Patapoutian provided a molecular and neural basis for thermosensation and mechanosensation.
This line of research holds out exciting medical possibilities, because it sheds light on how to reduce chronic and acute pain associated with a range of diseases, trauma and their treatments. In fact, several pharmaceutical laboratories are working to identify molecules that act on these receptors with the aim of treati ....

New York , United States , United Kingdom , Los Angeles , San Francisco , Robert Francis Furchgott , Ardem Patapoutian , Celis Ibeas , Angelika Schnieke , Luis Mart , Dolores Gonz , Isabel Varela Nieto , David Julius , Dario Alessi , Robin Lovell , Ali Shilatifard , M Isabel Medina , Bruce Whitelaw , Department Of Cellular , Department Of Animal Sciences , Foundation Frontiers Of Knowledge , Genomics Institute Of The Novartis Research Foundation , National Advisory Neurological Disorders , Department Of Neuroscience , Neyra Institute Of Parasitology , Technical University Of Munich ,